Randomized, open-label, multiple-dose study to evaluate the effect of omeprazole 20 mg on the pharmacokinetics of atazanavir administered with ritonavir in healthy subjects

Trial Profile

Randomized, open-label, multiple-dose study to evaluate the effect of omeprazole 20 mg on the pharmacokinetics of atazanavir administered with ritonavir in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Apr 2011

At a glance

  • Drugs Atazanavir; Omeprazole; Ritonavir
  • Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Gastrointestinal disorders; HIV-1 infections; Peptic ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 07 Apr 2011 Actual end date (1 Aug 2006) added as reported by ClinicalTrials.gov.
    • 10 May 2010 Results published in the Journal of Clinical Pharmacology.
    • 02 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top